Results From Phase 2b Study On Atrial Fibrillation Agent Reviewed At American Hear...
ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's ...
Medical News Today,
Wed Nov 18 19:22:19 PST 2009
• Found on Yahoo! News
Press Release
ARYx Therapeutics Inc. Posted on:18 Nov 09 ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL,...
PharmiWeb,
Wed Nov 18 02:11:06 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Review of the results of Phase 2b clinical trial on PASCAL announced
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx
News-Medical-Net,
Tue Nov 17 23:57:25 PST 2009
• Found on Yahoo! News
Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Hear...
FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of A...
Business Wire via Yahoo! Finance,
Tue Nov 17 21:00:00 PST 2009
• Found on Yahoo! News